Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171548
Status:
COMPLETED
Last Update Posted:
2008-09-22
First Post:
2005-09-12
Brief Title:
Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Project to Promote the Evaluation of Cardiovascular Risk in Clinical Practice and Assess Its Evolution After the Implementation of Multifactorial Preventive Strategy Aimed at Reducing the Level of Global Risk SCORE Algorithm in Subjects With Metabolic Syndrome and a Risk Level of 5
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Metabolic syndrome is commonly defined as a set of risk factors and abnormalities that markedly increase the risk of cardiovascular events Its relevance has been confirmed by a recent population-based survey of subjects aged 40-79 years indicating that the prevalence of metabolic syndrome in Italy is 341 if diagnosed using WHO criteria and 178 if diagnosed using the NCEP-ATPIII criteria
On the basis of the above considerations the aim of this study is to promote the use of the SCORE algorithm for estimating cardiovascular risk and to evaluate its evolution in patients with metabolic syndrome after the implementation of a multifactorial preventive strategy with particular reference to the correction of lifestyle hypertension and dyslipidemia
On the basis of the above considerations the aim of this study is to promote the use of the SCORE algorithm for estimating cardiovascular risk and to evaluate its evolution in patients with metabolic syndrome after the implementation of a multifactorial preventive strategy with particular reference to the correction of lifestyle hypertension and dyslipidemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None